Home › Steatotic Liver Disease › Florida › Orlando

Pag-aaral pangklinika para sa Steatotic Liver Disease sa Orlando, FL

9 pag-aaral para sa Steatotic Liver Disease ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Orlando (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Nagre-recruitPhase 3

89bio Clinical Study Site, Winter Park · 5 mi ang layo
89bio Clinical Study Site, Ocoee · 10 mi ang layo
89bio Clinical Study Site, Clermont · 24 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Nagre-recruitPhase 3

89bio Clinical Study Site, Winter Park · 5 mi ang layo
89bio Clinical Study Site, Maitland · 6 mi ang layo
89bio Clinical Study Site, Ocoee · 10 mi ang layo
at 1 pa

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06318169

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Nagre-recruitPhase 2

Charter Research LLC - Orlando, Orlando

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Nagre-recruitPhase 3

Charter Research - Orlando, Orlando
Headlands Research Orlando, Orlando
K2 Medical Research WINTER GARDEN, Clermont · 24 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Nagre-recruitPhase 3

Akero Clinical Study Site, Orlando

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Nagre-recruitPhase 3

GSK Investigational Site, Maitland · 6 mi ang layo
GSK Investigational Site, Kissimmee · 16 mi ang layo
GSK Investigational Site, Clermont · 24 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221188

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

AdventHealth Translational Research Institute, Orlando

Edad 25 hanggang 55 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT06993454

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Nagre-recruitPhase 3

GSK Investigational Site, Maitland · 6 mi ang layo
GSK Investigational Site, Kissimmee · 16 mi ang layo
GSK Investigational Site, Clermont · 24 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07221227

AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

AdventHealth Translational Research Institute, Orlando

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2025 · NCT04807868

Pag-aaral para sa Steatotic Liver Disease sa ibang lungsod

Iba pang pag-aaral sa Orlando

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.